A Phase II Trial of MB-6 Plus FOLFOX4 for Metastatic Colorectal Cancer (FDA IND 103675)
NCT01047475
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
72
Enrollment
INDUSTRY
Sponsor class
Conditions
Colorectal Cancer
Interventions
DRUG:
MB-6
DRUG:
Placebo
Sponsor
Microbio Co Ltd